Natrecor for Pulmonary Hypertension in Lung Transplants
Condition(s):Pulmonary HypertensionLast Updated:October 14, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Pulmonary HypertensionLast Updated:October 14, 2015Completed
Condition(s):Diabetes Mellitus; CardiomyopathyLast Updated:March 29, 2011Completed
Condition(s):Congestive Heart Failure; Renal InsufficiencyLast Updated:September 12, 2013Completed
Condition(s):Heart Defects, Congenital; Cardiopulmonary BypassLast Updated:August 27, 2020Terminated
Condition(s):Cardiorenal SyndromeLast Updated:November 6, 2017Terminated
Condition(s):Heart Failure, Congestive; Dyspnea; Pulmonary EdemaLast Updated:November 11, 2015Withdrawn
Condition(s):Congestive Heart Failure; Cardiorenal SyndromeLast Updated:February 8, 2016Terminated
Condition(s):Acute Myocardial InfarctionLast Updated:September 9, 2014Completed
Condition(s):Heart Failure; Cardiovascular Disease; Acute Heart Failure; Diastolic Heart Failure; Congestive Heart Failure; Heart DiseaseLast Updated:November 7, 2018Terminated
Condition(s):Congestive Heart Failure; Mechanical Ventilation; Using Nesiritide; Venous Return; Cardiac FunctionLast Updated:July 2, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.